Exploratory/Developmental Bioengineering Research Grants (EBRG)
National Institutes of Health (NIH)
Total budget not exceeding $275,000
Maximum project period of 2 years
To support exploratory/developmental bioengineering research that demonstrates feasibility and potential utility.
To improve quality, speed, efficacy, operability, costs, and accessibility of biomedical solutions.
Researchers in bioengineering and biomedical fields
Patients and healthcare providers
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, and government entities.
Specific qualifications include having the necessary skills, knowledge, and resources to carry out the proposed research.
Eligible organizations include U.S. and non-U.S. entities.
Foreign components of U.S. organizations are allowed.
Projects must demonstrate feasibility and potential utility of new capabilities.
Applications proposing phase III clinical trials are not supported.
Total direct costs for the project may not exceed $275,000.
No more than $200,000 may be requested in any single year.
Applications are due by 5:00 PM local time of the applicant organization.
Key dates include opening date on January 16, 2025, and closing date on January 7, 2028.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
The NIH will not accept duplicate or overlapping applications under review at the same time.
Applications must follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on significance, innovation, rigor, feasibility, and expertise.
Applications will undergo scientific peer review and may receive a second level of review by the Advisory Council.
Scientific and technical merit of the proposed project will be a primary consideration.
Applications must address a Data Management and Sharing Plan.
Applications proposing studies of basic science aspects of cancer biology are not responsive.
Encourages multidisciplinary approaches to biomedical challenges.
Innovative proposals that challenge accepted paradigms may have a competitive edge.
Demonstrating feasibility and potential utility of proposed solutions.
Submitting overlapping applications or failing to comply with application instructions.
Engage in multidisciplinary collaborations to enhance proposal strength.
Highlight innovative aspects and potential impact on cancer research.